Injective (INJ) Drops 5% Amid Short-Term Correction

Understanding Injective (INJ)’s Recent Price Movement

Injective (INJ)’s recent 4–5 percentage-point move over the past 2 days is best explained by a short-term correction and profit taking after a strong catalyst-driven run, not by any new negative fundamental event.

Strong Catalyst Cluster Set Up A Pullback

Before the recent 47-hour window, INJ had already been in a strong upswing, driven by a dense cluster of positive, high-profile catalysts. These created both fundamental optimism and a crowded trade that is now being partially unwound.

Key recent positives include:

1. Robinhood listing and Coinbase mainnet migration

1. Regulatory and institutional positioning: SEC transfer agent filing and MiCA whitepaper

1. Ecosystem and AI / on-chain finance narrative

These catalysts helped drive INJ’s earlier weekly gains (around +11% at one point) and pushed price into a resistance zone near $5.50–$5.60.[^altcoins-yahoo] When a token has already priced in a lot of good news, even neutral or slightly positive follow-through often leads to consolidation or pullbacks as traders take profits.

The 47-hour move you are asking about is happening after a series of objectively bullish injections of news and liquidity. That makes a “hangover” style correction the default expectation unless new upside catalysts appear.

Exchange Inflows, Chart Setups, And Profit Taking

Within the last week, there are clear signs that speculative capital moved from accumulation into distribution, which is a very likely proximate cause of INJ’s short-term drop.

1. Large INJ inflows to centralized exchanges

1. DeXe saw heavy exchange inflows, volume spikes, and negative CVD before an 85% crash.

The piece concludes that DeFi liquidity is rotating and explicitly warns that INJ may be at risk of a similar correction if those inflows translate into sell pressure.[^dexe-rotation]

Even if we do not see an 85% crash, the presence of this much fresh sell-side inventory on exchanges is exactly the kind of flow that produces a multi-percentage-point pullback like the 4.19-point move you cited.

1. Short-term technicals turned from breakout to “double top” and sell signals

1. A widely shared thread on X flags a double top pattern on INJ, noting that price tested the same resistance twice and warning that a break below the neckline could accelerate bearish momentum.[^double-top-x]

When such views are widely circulated, they can: 1. Trigger short-term longs to de-risk. 2. Attract short sellers around visible resistance. 3. Reinforce a feedback loop where small dips quickly extend into multi-percentage-point moves.

1. 24-hour snapshot is consistent with an ongoing, not yet exhausted, correction

1. Down about 3.65% over the last 24 hours.

Those numbers fit the pattern you describe: a coin that rallied strongly on news, then rolled over into a controlled but real short-term drawdown rather than a collapse.

The most concrete, near-term drivers of INJ’s 4-plus-percentage-point move are exchange inflows and technical rejection at resistance, which unleashed profit taking and short-term bearish positioning on top of an already extended chart.

Market Backdrop And New Tokenization Pilot

The last piece is the broader crypto tape and one fresh piece of Injective-specific fundamental news that hit during your 47-hour window.

1. Broader market is slightly weak, with “fear” sentiment

1. Total crypto market cap is roughly 2.21 trillion dollars, off about 1.2% over the last week.

In this context, a mid-cap alt like INJ underperforming the aggregate by a few percentage points after a strong run is quite typical. It reflects: 1. Beta to a soft tape. 2. Additional idiosyncratic profit taking after outsized recent gains.

1. New RWA trade-finance pilot: bullish, but still just a pilot

Key aspects: 1. The pilot uses real trade receivables from POSCO’s international subsidiaries, not synthetic demo data. 2. Claims are issued, transferred, and settled on Injective as on-chain assets, creating a shared ledger among buyers, sellers, and banks. 3. Compliance rules are embedded in the tokens, and the project is explicitly positioned as a step toward production later in 2026.

This is a strong validation for Injective’s RWA and trade-finance narrative, but the articles are careful to stress that: 1. It is a proof-of-concept, involving a limited number of transactions so far. 2. No public performance or scale metrics have been disclosed yet.

In practice, that kind of news: 1. Supports the medium-term bull case for INJ. 2. But does not necessarily prompt immediate large buying, especially if released into an already extended chart with ongoing profit taking.

1. Net effect over the last 47 hours

1. INJ entered the period coming off a summit-driven and listing-driven rally into resistance.

The 4.19-point move is not tied to a single “bad”